Cargando...
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2019-10-01
|
| Colección: | Cancers |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2072-6694/11/10/1584 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|